Prognostic Factors Affecting Hearing in Otitis Media With ANCA-Associated Vasculitis Patients: A Systematic Review and Meta-Analysis

To conduct a systematic review and meta-analysis of clinical studies describing the possible prognostic factors affecting hearing outcomes in Otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) patients. To provide guidance for clinical work, avoiding profound...

Full description

Saved in:
Bibliographic Details
Published inEar, nose, & throat journal p. 1455613231200488
Main Authors Li, Chen, Xie, Mengyao, Wu, Zhiyuan, Wang, Shu, Han, Zhijin, Tang, Qi, Xue, Ruoyan, Zhang, Yongli, Yang, Hua
Format Journal Article
LanguageEnglish
Published United States 04.10.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To conduct a systematic review and meta-analysis of clinical studies describing the possible prognostic factors affecting hearing outcomes in Otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) patients. To provide guidance for clinical work, avoiding profound irreversible hearing loss affecting patients' lives. A literature search was performed in PubMed, MEDLINE, EMBASE, Cochrane, Scopus, and Web of Science to identify English articles published before December 1, 2022. After screening the articles, the Newcastle-Ottawa Scale (NOS) was used to assess the risk of bias of the extracted literature, and studies with high quality (score > 6) were included. Four studies were included: 1 was a retrospective cohort study, and 3 were case-control studies. We performed a meta-analysis of 4 factors: facial palsy, hypertrophic pachymeningitis, ANCA-negative status, and the period from onset to diagnosis. The results showed that there was a significant association between facial palsy [odds ratio (OR) 1.51; 95% confidence interval (CI) 1.07-2.15; = 0%; = .02], hypertrophic pachymeningitis (OR 1.73; 95% CI 1.18-2.53; = 24%; = .005), ANCA negativity (OR 1.75; 95% CI 1.11-2.77; = 33; = .02), and poor hearing prognosis in OMAAV patients. However, the period from onset to diagnosis (SEM ± SD 2.54; 95% CI -1.56 to 6.64; = 98%; = .22) of OMAAV was not significantly associated with poor hearing outcomes. We found that OMAAV patients with facial palsy, hypertrophic pachymeningitis, and ANCA negativity have a significant association with poor hearing prognosis, which provides diagnosis and treatment guidance in protecting patients' hearing.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0145-5613
1942-7522
DOI:10.1177/01455613231200488